AstraZeneca Pharmaceuticals LP
Registered Principal Details
Business Or Interest:
Research, development and sales of pharmaceuticals
Lobbying Interests:
All matters pertaining to the researching, development marketing, sale and distribution of medications.
CEO Name:
David Brennen
Executive Director
Research, development and sales of pharmaceuticals
Lobbying Interests:
All matters pertaining to the researching, development marketing, sale and distribution of medications.
CEO Name:
David Brennen
Executive Director
Contact
CB
Christine Barnett
PO Box 15437
Wilmington, DE 19850-5737
(302) 885-5412
(302) 885-1110
christine.barnett@astrazeneca.com
www.astrazeneca.com
PO Box 15437
Wilmington, DE 19850-5737
(302) 885-5412
(302) 885-1110
christine.barnett@astrazeneca.com
www.astrazeneca.com
Authorized Lobbyists
| Lobbyist Name | Exclusive Duties | Authorized On | Withdrawn On |
|---|
Lobbying Interests
Legislative Bills/Resolutions
Assembly Bill 56
Relating to: advertising for prescription drugs.
Bill Text and History
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: advertising for prescription drugs.
Bill Text and History
None
Notification Date7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 227
Relating to: directing the Pharmacy Examining Board to create a program to monitor the dispensing of prescription drugs and requiring the exercise of rule-making authority.
Bill Text and History
2009 Wisconsin Act 362
9/15/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Relating to: directing the Pharmacy Examining Board to create a program to monitor the dispensing of prescription drugs and requiring the exercise of rule-making authority.
Bill Text and History
2009 Wisconsin Act 362
None
Notification Date9/15/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Topics Not Yet Assigned A Bill Or Rule Number
Development, drafting or introduction of a proposal relating to
Combined Reporting
Combined Reporting
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicaid
Medicaid
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicare
Medicare
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Phamaceutical Companies
Phamaceutical Companies
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Prescriber Data
Prescriber Data
Action Intended To Affect
Both Legislative Matter and Rule
Notification Date
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Both Legislative Matter and Rule
Notification Date
7/16/2009
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicaid
Medicaid
Action Intended To Affect
Legislative Matter
Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Medicare
Medicare
Action Intended To Affect
Legislative Matter
Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Development, drafting or introduction of a proposal relating to
Pharmaceutical Companies
Pharmaceutical Companies
Action Intended To Affect
Legislative Matter
Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Legislative Matter
Notification Date
4/17/2007
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Total Lobbying Effort
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total | |
|---|---|---|---|---|---|
| Total Lobbying Expenditures | 2009 January - June $40,428.62 |
2009 July - December $7,478.25 |
2010 January - June $5,013.67 |
2010 July - December $2,850.91 |
Total $55,771.45 |
| Total Hours Communicating | 2009 January - June 108.00 |
2009 July - December 87.00 |
2010 January - June 33.00 |
2010 July - December 17.00 |
Total 245.00 |
| Total Hours Other | 2009 January - June 197.00 |
2009 July - December 92.00 |
2010 January - June 18.00 |
2010 July - December 12.00 |
Total 319.00 |
Percent Allocation of Lobbying Effort
Legislative Bills/Resolutions
No legislative bills/resolutions found.
Budget Bill Subjects
No budget bill subjects found.
Administrative Rulemaking Proceedings
No administrative rulemaking proceedings found.
Topics Not Yet Assigned A Bill Or Rule Number
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June 25% |
2009 July - December 25% |
2010 January - June 25% |
2010 July - December 25% |
Total 25% |
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June 25% |
2009 July - December 25% |
2010 January - June 25% |
2010 July - December 25% |
Total 25% |
| 2009 January - June |
2009 July - December |
2010 January - June |
2010 July - December |
Total |
|---|---|---|---|---|
| 2009 January - June 25% |
2009 July - December 25% |
2010 January - June 25% |
2010 July - December 25% |
Total 25% |
Minor Efforts
(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)
Other Matters
No other matters found.